3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
2
Prostatic Neoplasms
1
Disease
1
Interventions
Prednisone
3
pembrolizumab
2
Melphalan
2
Cytarabine
2
venetoclax
1
ofatumumab
1
obinutuzumab
1
ioflupane
1
imetelstat
1
ibrutinib
1
gossypol acetic acid
1
gilteritinib
1
fluorocholine
1
fluciclovine F-18
1
deltacortene
1
daratumumab
1
aflibercept
1
abiraterone
1
Temozolomide
1
Self-Management
1
Quality of Life
1
Professional Autonomy
1
Paclitaxel
1
Oncolytic Virotherapy
1
Octreotide
1
Mitoxantrone
1
Methylene Blue
1
Lenalidomide
1
Gemtuzumab
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Disease
×
fluorocholine
×
Clear all
NCT04965454
2025-05-01
ExTRACT-HCC
Queen's Medical Center
Phase 2
Recruiting
80 enrolled